AUPH
Aurinia Pharmaceuticals Inc.
NASDAQ · Healthcare · Biotechnology · CA
$16.08
−0.25%Margins
Gross margin
90.4%
EBITDA margin
60.4%
EBIT margin
48.4%
Net margin
100.8%
FCF margin
55.7%
51.1%
Return on equity
39.6%
Return on assets
22.3%
Return on invested capital
0.41x
Asset turnover
$173.8M
Cash from operations
$3.33
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026